Dr. Reddy's Laboratories Ltd.

15/03/2026

We are live. Join us on the link now: https://www.youtube.com/live/UmyuGAA-e0w?si=FKJxzIUQpXSliumP

Scientist, entrepreneur and philanthropist Dr. Kallam Anji Reddy was among the pioneers of the Indian pharma industry. He was extremely passionate about drug...

13/03/2026

The fourth Dr. Anji Reddy Memorial Lecture is just around the corner on Sunday, 15 March at 10 am. Block your calendars now!

This year, we welcome Professor Guido Kroemer, recipient of the Léopold Griffuel Prize, and Dr. Guru N. Reddy, Founder and Chairman of Continental Hospitals, as our keynote speakers. These sessions promise their unique perspective on scientific discoveries, honest insights and a humane view of how knowledge becomes better care for us all.

Launched in 2023, this annual lecture series has grown into a thoughtful space at the intersection of science, society, and sustainability, the very principles that guided our founder’s life and work. As we continue this journey, we invite you to join us online to celebrate the vision of Dr. K. Anji Reddy, the scientist, entrepreneur, and philanthropist who continues to inspire us.

YouTube Live link: https://www.youtube.com/live/UmyuGAA-e0w

08/03/2026

This , we explored how women see themselves at work and how their colleagues see them.

When someone said, “I’m trying,” a colleague saw them as “someone who sets things in motion.”
When she said, “I’m still learning,” others felt, “She helps the rest of us learn better.”
When she recognized her team, her team described her presence as “calming”

These gentle contrasts reminded us how we often know the value women bring to the spaces we share. Yet, they tend to undervalue themselves and even we don’t always say it out loud.
Say It Unconditionally is our attempt to give voice to what we already feel, and to ensure appreciation is spoken in ways women can truly hear.

28/02/2026

We wrapped up the month long Celebration of Excellence yesterday with an awards night. Though it was the last in a series of activities spanning the month and across the geographies where we are present, the event felt less like an ending and more like a reminder of who we are.

Our theme this year, Excellence by Design, captured the way we think, act, and build together with purpose. And while the spotlight was on our awardees last night, they’re really just a glimpse of the many extraordinary people who make Dr. Reddy’s what it is.

What stood out most was the feeling of togetherness — teams and leaders cheering for one another, proud of each other, connected in a way that reminds us why we do what we do.

We’ll let the pictures do the talking from here. Take your time.

20/02/2026

We have acquired the trademarks of the specialty brands Progynova® and Cyclo‑Progynova®, and related assets for India. This acquisition marks our entry into the Hormone Replacement Therapy segment and strengthens our gynaecology portfolio.
Click here to read more: https://shorturl.at/3jmz5

18/02/2026

On Day 2 of BioAsia 2026, Dr. Murali Ramachandra, CEO of Aurigene Oncology, shared his take on “India’s Innovation Moment: Scaling the Next Phase of Global Impact.”

He acknowledged the significance of regulatory reforms, improving funding avenues, and a more supportive environment for innovation in creating real momentum for Indian pharma.

18/02/2026

At the CEO Conclave at BioAsia 2026, our Managing Director and Co Chairman G. V. Prasad spoke on “The Future of Pharma & Biotech: Growth, Headwinds & Opportunities” and shared his views on India’s preparedness to become an R&D and innovation hub in the coming future.

He highlighted how India has firmly established itself as the generic pharmacy of the world, and how the next decade will bring more biologics, more biosimilars, and continued strength in generics, with steady growth in research and services. He emphasised that the most meaningful shift underway is the entry of global majors setting up R&D and innovation capabilities in India, strengthening talent, partnerships, and the overall ecosystem.

17/02/2026

Our Chairman Satish Reddy was felicitated for Dr. Reddy’s long-standing partnership with the BioAsia: The Global Biobusiness Forum by Shri A. Revanth Reddy, Hon’ble Chief Minister of Telangana, and Shri D. Sridhar Babu, Hon’ble Minister for Industries and Commerce, Govt. of Telangana.

Here’s how he captured the spirit of the moment during the opening session of the conference’s 23rd edition:

“BioAsia has always been special because it’s where science meets scale and where big ideas turn into real collaboration. Telangana’s journey in life sciences has been extraordinary, and today we’re at the cusp of another leap with AI, automation, and data-driven biology. I’m excited for the conversations here — because what we build together over these days will shape the future of healthcare.”

09/02/2026

Our Chairman, Satish Reddy, on the proposed India–US interim trade agreement and its potential to enable new opportunities for Indian industry.

09/02/2026

For years, animal models have been the default in drug development. They have helped science move forward, but they have also shown limits, especially in high failure rates and time lost for patients.

A multistakeholder study, “Landscape Analysis on Alternatives to Animal Testing for Drug Development in India”, jointly developed in association with Humane World for Animals India, DBT-InSTEM, Animal Law and Policy Network highlights how non animal, human relevant methods can strengthen research while supporting better outcomes for patients and reducing harm to animals.

If you care about animals, science, research quality, and access to better medicines, read the complete article. Link to digital edition is in comments.

07/02/2026

We have received the Gold Shield at the ICAI Awards for Excellence in Financial Reporting 2024-25, conferred by the The Institute of Chartered Accountants of India (ICAI) in the Manufacturing and Trading category for organisations with a turnover of ₹5,000 crore and above.

The honour recognises quality of our financial reporting, transparency and adherence to the highest standards of accounting and disclosure practices.